These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27686308)

  • 1. Serum YKL-40 and MDA levels in Behcet disease.
    Bilen H; Altinkaynak K; Sebin E; Aksoy H; Akcay F
    J Pak Med Assoc; 2016 Oct; 66(10):1299-1302. PubMed ID: 27686308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
    Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin levels in Behçet's disease.
    Kandi B; Cicek D; Ilhan N
    J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
    Najim RA; Sharquie KE; Abu-Raghif AR
    J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Sandikci R; Türkmen S; Güvenen G; Ayabakan H; Gülcan P; Koldas M; Ozbek Kir Z; Yenice N
    Acta Derm Venereol; 2003; 83(5):342-6. PubMed ID: 14609100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease.
    Aydin E; Sögüt S; Ozyurt H; Ozugurlu F; Akyol O
    Ophthalmic Res; 2004; 36(3):177-82. PubMed ID: 15103210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation and homocysteine levels in Behçet's disease.
    Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
    Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mevalonate kinase gene mutations and their clinical correlations in Behçet's disease.
    Arslan Taş D; Erken E; Yildiz F; Dinkçi S; Sakalli H
    Int J Rheum Dis; 2014 May; 17(4):435-43. PubMed ID: 24411001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the arterial intima-media thickness in Behcet's disease patients without vascular complaints.
    Kankilic N; Aslan A; Karahan O; Demirtas S; Caliskan A; Yavuz C
    Vascular; 2018 Aug; 26(4):356-361. PubMed ID: 29182089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiannexin V autoantibody in thrombophilic Behçet's disease.
    Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
    Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum YKL-40 in Behçet disease.
    Seo J; Ahn Y; Zheng Z; Kim BO; Choi MJ; Bang D; Kim DY
    Br J Dermatol; 2016 Jun; 174(6):1337-44. PubMed ID: 26708309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in patients with Behçet's disease.
    Bicer A; Tursen U; Kaya TI; Ozer C; Camdeviren H; Ikizoglu G; Erdogan C
    Rheumatol Int; 2004 Nov; 24(6):355-8. PubMed ID: 14556035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.